MicroRNA-148a regulates low-density lipoprotein metabolism by repressing the (pro)renin receptor

Na Wang; Lishu He; Hui Lin; Lunbo Tan; Yuan Sun; Xiaoying Zhang; A. H. Jan Danser; Hong S. Lu; Yongcheng He; Xifeng Lu

doi:10.1371/journal.pone.0225356

MicroRNA-148a regulates low-density lipoprotein metabolism by repressing the (pro)renin receptor

Na Wang, Lishu He, Hui Lin, Lunbo Tan, Yuan Sun, Xiaoying Zhang, A. H. Jan Danser, Hong S. Lu, Yongcheng He, Xifeng Lu

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

High plasma LDL cholesterol (LDL-c) concentration is a major risk factor for atherosclerosis. Hepatic LDL receptor (LDLR) regulates LDL metabolism, and thereby plasma LDL-c concentration. Recently, we have identified the (pro)renin receptor [(P)RR] as a novel regulator of LDL metabolism, which regulates LDLR degradation and hence its protein abundance and activity. In silico analysis suggests that the (P)RR is a target of miR-148a. In this study we determined whether miR-148a could regulate LDL metabolism by regulating (P)RR expression in HepG2 and Huh7 cells. We found that miR-148a suppressed (P)RR expression by binding to the 3’-untranslated regions (3’-UTR) of the (P)RR mRNA. Mutating the binding sites for miR-148a in the 3’-UTR of (P)RR mRNA completely abolished the inhibitory effects of miR-148a on (P)RR expression. In line with our recent findings, reduced (P)RR expression resulted in decreased cellular LDL uptake, likely as a consequence of decreased LDLR protein abundance. Overexpressing the (P)RR prevented miR-148a-induced reduction in LDLR abundance and cellular LDL uptake. Our study supports a new concept that miR-148a is a regulator of (P)RR expression. By reducing (P)RR abundance, miR-148a decreases LDLR protein abundance and consequently cellular LDL uptake.

Original language	English
Article number	e0225356
Journal	PLoS ONE
Volume	15
Issue number	5
DOIs	https://doi.org/10.1371/journal.pone.0225356
State	Published - May 2020

Bibliographical note

Funding Information:
This work is supported by National Natural Science Foundation of China (grant no. 81870605, 81800383, 81500667) and Shenzhen Municipal Science and Technology Innovation Council (grant no. JCYJ20160307160819191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Publisher Copyright:
© 2020 Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

ASJC Scopus subject areas

General

Access to Document

10.1371/journal.pone.0225356

Cite this

@article{59074635608a49e6a64a597e9ddaa50a,

title = "MicroRNA-148a regulates low-density lipoprotein metabolism by repressing the (pro)renin receptor",

abstract = "High plasma LDL cholesterol (LDL-c) concentration is a major risk factor for atherosclerosis. Hepatic LDL receptor (LDLR) regulates LDL metabolism, and thereby plasma LDL-c concentration. Recently, we have identified the (pro)renin receptor [(P)RR] as a novel regulator of LDL metabolism, which regulates LDLR degradation and hence its protein abundance and activity. In silico analysis suggests that the (P)RR is a target of miR-148a. In this study we determined whether miR-148a could regulate LDL metabolism by regulating (P)RR expression in HepG2 and Huh7 cells. We found that miR-148a suppressed (P)RR expression by binding to the 3{\textquoteright}-untranslated regions (3{\textquoteright}-UTR) of the (P)RR mRNA. Mutating the binding sites for miR-148a in the 3{\textquoteright}-UTR of (P)RR mRNA completely abolished the inhibitory effects of miR-148a on (P)RR expression. In line with our recent findings, reduced (P)RR expression resulted in decreased cellular LDL uptake, likely as a consequence of decreased LDLR protein abundance. Overexpressing the (P)RR prevented miR-148a-induced reduction in LDLR abundance and cellular LDL uptake. Our study supports a new concept that miR-148a is a regulator of (P)RR expression. By reducing (P)RR abundance, miR-148a decreases LDLR protein abundance and consequently cellular LDL uptake.",

author = "Na Wang and Lishu He and Hui Lin and Lunbo Tan and Yuan Sun and Xiaoying Zhang and {Jan Danser}, {A. H.} and Lu, {Hong S.} and Yongcheng He and Xifeng Lu",

note = "Funding Information: This work is supported by National Natural Science Foundation of China (grant no. 81870605, 81800383, 81500667) and Shenzhen Municipal Science and Technology Innovation Council (grant no. JCYJ20160307160819191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Publisher Copyright: {\textcopyright} 2020 Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.",

year = "2020",

month = may,

doi = "10.1371/journal.pone.0225356",

language = "English",

volume = "15",

number = "5",

}

TY - JOUR

T1 - MicroRNA-148a regulates low-density lipoprotein metabolism by repressing the (pro)renin receptor

AU - Wang, Na

AU - He, Lishu

AU - Lin, Hui

AU - Tan, Lunbo

AU - Sun, Yuan

AU - Zhang, Xiaoying

AU - Jan Danser, A. H.

AU - Lu, Hong S.

AU - He, Yongcheng

AU - Lu, Xifeng

N1 - Funding Information: This work is supported by National Natural Science Foundation of China (grant no. 81870605, 81800383, 81500667) and Shenzhen Municipal Science and Technology Innovation Council (grant no. JCYJ20160307160819191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Publisher Copyright: © 2020 Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PY - 2020/5

Y1 - 2020/5

N2 - High plasma LDL cholesterol (LDL-c) concentration is a major risk factor for atherosclerosis. Hepatic LDL receptor (LDLR) regulates LDL metabolism, and thereby plasma LDL-c concentration. Recently, we have identified the (pro)renin receptor [(P)RR] as a novel regulator of LDL metabolism, which regulates LDLR degradation and hence its protein abundance and activity. In silico analysis suggests that the (P)RR is a target of miR-148a. In this study we determined whether miR-148a could regulate LDL metabolism by regulating (P)RR expression in HepG2 and Huh7 cells. We found that miR-148a suppressed (P)RR expression by binding to the 3’-untranslated regions (3’-UTR) of the (P)RR mRNA. Mutating the binding sites for miR-148a in the 3’-UTR of (P)RR mRNA completely abolished the inhibitory effects of miR-148a on (P)RR expression. In line with our recent findings, reduced (P)RR expression resulted in decreased cellular LDL uptake, likely as a consequence of decreased LDLR protein abundance. Overexpressing the (P)RR prevented miR-148a-induced reduction in LDLR abundance and cellular LDL uptake. Our study supports a new concept that miR-148a is a regulator of (P)RR expression. By reducing (P)RR abundance, miR-148a decreases LDLR protein abundance and consequently cellular LDL uptake.

AB - High plasma LDL cholesterol (LDL-c) concentration is a major risk factor for atherosclerosis. Hepatic LDL receptor (LDLR) regulates LDL metabolism, and thereby plasma LDL-c concentration. Recently, we have identified the (pro)renin receptor [(P)RR] as a novel regulator of LDL metabolism, which regulates LDLR degradation and hence its protein abundance and activity. In silico analysis suggests that the (P)RR is a target of miR-148a. In this study we determined whether miR-148a could regulate LDL metabolism by regulating (P)RR expression in HepG2 and Huh7 cells. We found that miR-148a suppressed (P)RR expression by binding to the 3’-untranslated regions (3’-UTR) of the (P)RR mRNA. Mutating the binding sites for miR-148a in the 3’-UTR of (P)RR mRNA completely abolished the inhibitory effects of miR-148a on (P)RR expression. In line with our recent findings, reduced (P)RR expression resulted in decreased cellular LDL uptake, likely as a consequence of decreased LDLR protein abundance. Overexpressing the (P)RR prevented miR-148a-induced reduction in LDLR abundance and cellular LDL uptake. Our study supports a new concept that miR-148a is a regulator of (P)RR expression. By reducing (P)RR abundance, miR-148a decreases LDLR protein abundance and consequently cellular LDL uptake.

UR - http://www.scopus.com/inward/record.url?scp=85085156693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85085156693&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0225356

DO - 10.1371/journal.pone.0225356

M3 - Article

C2 - 32437440

AN - SCOPUS:85085156693

SN - 1932-6203

VL - 15

JO - PLoS ONE

JF - PLoS ONE

IS - 5

M1 - e0225356

ER -

MicroRNA-148a regulates low-density lipoprotein metabolism by repressing the (pro)renin receptor

Abstract

Bibliographical note

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this